CartaBio
PrivateLast Round
Angel
Apr 25, 2024
Total Funding Raised
$2.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CartaBio is a biotechnology company that develops diagnostic technology and an AI-driven platform to decode cellular behavior for the advancement of immune-modulating therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CartaBio Comparables
Compare CartaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvolutionaryScale | 84% | |
| Nabla Bio | 81% | |
| Cradle | 79% |
CartaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Apr 25, 2024 |
CartaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coho Deeptech | Angel |
| Danen Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 1057% MoM, from 92 to 1.1K.
- Apr 25, 2024
$3M raised from Danen Capital and Coho Deeptech.
CartaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CartaBio's valuation, stock price, and market status.
Is CartaBio a public or private company?
CartaBio is a private company.
What is the current stock price of CartaBio?
CartaBio is a private company with no public stock price. Caplight tracks CartaBio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CartaBio worth (valuation)?
Valuation information for CartaBio is not publicly available.
Can I buy CartaBio stock?
CartaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CartaBio's last funding round?
CartaBio's most recent funding round was Angel on April 25, 2024.
Who are the main investors in CartaBio?
Key investors in CartaBio include Coho Deeptech, Danen Capital.
Will CartaBio IPO soon?
No public IPO plans have been announced for CartaBio.
How can I track CartaBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CartaBio's secondary market activity and sign up for updates.